David McBay

Focus Therapy Areas: Oncology, Haematology, Immunology

Specialist Expertise: Cell & Gene Therapies, Digital Therapeutics, Value-Based Healthcare

Education: PhD Institute of Cancer Research; MSci Genetics University College London

What is your focus at Eradigm?

My focus is on delivering the highest quality of personalised, impactful research and insights that align with our client’s priorities to drive significant impact in Competitive Intelligence and Market Access. I work more often in clinically-focussed Competitive Intelligence, particularly to inform cell & gene therapy strategy.

Who do you work with?

I work with global Market Access, Competitive & Market Intelligence & Brand team leads across top 10 biopharma companies, in addition to cell and gene therapy focussed biotech. I have also recently worked with senior biopharma leadership on broader corporate strategy.

What is your specialist expertise, and what types of projects do you work on?

Global CI, particularly in the US for oncology and immunology; Global Market Access for cell and gene therapies; ‘beyond the pill’ commercial strategy and digital therapeutic corporate strategy are personal areas of expertise.

What did you do before Eradigm?

Before joining Eradigm, I undertook a PhD in DNA Damage Repair & Radiotherapy at the ICR, a particularly unique university given its biopharma industry partnerships and translational focus. I complimented my scientific studies by gaining commercial exposure through direct involvement on the ICR’s Board of Trustees. 

What are your passions outside of work?

Outside of work, I’m passionate about a five-a-side kayaking team sport called ‘Canoe Polo’, competing at an international level, including the CPSL Super League. I also have a love for conservation and travelling that I combine through amateur wildlife photography.